Nvidia restarts China chip production following regulatory breakthrough
Nvidia (NASDAQ:NVDA) has begun restarting its manufacturing lines for H200 processors destined for the Chinese market, according to CEO Jensen Huang.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Nvidia (NASDAQ:NVDA) has begun restarting its manufacturing lines for H200 processors destined for the Chinese market, according to CEO Jensen Huang.
One Stop Systems (NASDAQ:OSS) reported a transformative fourth quarter for the fiscal year ended December 31, 2025, marked by explosive top-line growth and a significant shift in its corporate structure.
Williams-Sonoma (NYSE:WSM) reported financial results for the fourth quarter and fiscal year ended February 1, 2026, revealing a resilient top line tempered by significant macroeconomic headwinds.
TOYO (NASDAQ:TOYO) reported preliminary, unaudited financial results for the fiscal year ended December 31, 2025, highlighting a transformative year of global capacity expansion and robust shipment volumes.
Protagonist Therapeutics (NASDAQ:PTGX) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 and older weighing at least 40 kg.
The Progressive Corporation (NYSE:PGR) released its monthly financial results for February 2026, demonstrating continued growth in its customer base and sustained underwriting profitability.
Dogwood Therapeutics (NASDAQ:DWTX) reported its fourth-quarter and full-year 2025 financial results, highlighting a pivot toward late-stage clinical development for its lead analgesic candidate, Halneuron®.
Lifeward (NASDAQ:LFWD) reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 18, 2026, highlighting a year of significant structural changes and improved reimbursement access.
Cingulate (NASDAQ:CING) announced its fourth-quarter and full-year 2025 financial results alongside several critical regulatory milestones on March 18, 2026.
InspireMD (NASDAQ:NSPR) reported a significant acceleration in its commercial operations for the fourth quarter of 2025, fueled by the successful U.S. market introduction of its CGuard Prime Carotid Stent System.
Kanzhun (NASDAQ:BZ), the leading online recruitment platform in China, reported a significant leap in profitability for the 2025 fiscal year, driven by steady revenue growth and a dramatic improvement in operating efficiency.
Jabil (NYSE:JBL) today reported preliminary, unaudited financial results for its second quarter of fiscal year 2026, delivering a performance that exceeded internal guidance and Wall Street consensus.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade